OpenClaw before 2026.3.11 contains a privilege escalation vulnerability in device.token.rotate that allows callers with operator.pairing scope to mint tokens with broader scopes by failing to constrain newly minted scopes to the caller's current scope set. Attackers can obtain operator.admin tokens for paired devices and achieve remote code execution on connected nodes via system.run or gain unauthorized gateway-admin access.

Project Subscriptions

Vendors Products
Openclaw Subscribe
Openclaw Subscribe
Advisories

No advisories yet.

Fixes

Solution

No solution given by the vendor.


Workaround

No workaround given by the vendor.

History

Sun, 29 Mar 2026 13:15:00 +0000

Type Values Removed Values Added
Description OpenClaw before 2026.3.11 contains a privilege escalation vulnerability in device.token.rotate that allows callers with operator.pairing scope to mint tokens with broader scopes by failing to constrain newly minted scopes to the caller's current scope set. Attackers can obtain operator.admin tokens for paired devices and achieve remote code execution on connected nodes via system.run or gain unauthorized gateway-admin access.
Title OpenClaw < 2026.3.11 - Privilege Escalation via Unvalidated Scope in device.token.rotate
First Time appeared Openclaw
Openclaw openclaw
Weaknesses CWE-266
CPEs cpe:2.3:a:openclaw:openclaw:*:*:*:*:*:node.js:*:*
Vendors & Products Openclaw
Openclaw openclaw
References
Metrics cvssV3_1

{'score': 9.9, 'vector': 'CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H'}

cvssV4_0

{'score': 9.4, 'vector': 'CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H'}


Projects

Sign in to view the affected projects.

cve-icon MITRE

Status: PUBLISHED

Assigner: VulnCheck

Published:

Updated: 2026-03-29T12:44:22.872Z

Reserved: 2026-03-16T21:19:31.966Z

Link: CVE-2026-32922

cve-icon Vulnrichment

No data.

cve-icon NVD

Status : Received

Published: 2026-03-29T13:17:00.573

Modified: 2026-03-29T13:17:00.573

Link: CVE-2026-32922

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses